LPAM
GILD icon

Lodestar Private Asset Management’s Gilead Sciences GILD Stock Holding History

Lodestar Private Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$290K Sell
2,293
-150
-6% -$19.8K 0.03% 193
2026
Q1 		$341K Sell
2,443
-50
-2% -$7K 0.03% 179
2025
Q4 		$306K Sell
2,493
-378
-13% -$45.9K 0.03% 189
2025
Q3 		$319K Sell
2,871
-12
-0.4% -$1.36K 0.03% 184
2025
Q2 		$320K Buy
2,883
+43
+2% +$4.58K 0.04% 180
2025
Q1 		$318K Buy
2,840
+100
+4% +$10.3K 0.04% 170
2024
Q4 		$253K Hold
2,740
– – 0.03% 194
2024
Q3 		$230K Buy
+2,740
New +$209K 0.03% 206
2024
Q2 		– Sell
-2,804
Closed -$205K – 210
2024
Q1 		$205K Sell
2,804
-312
-10% -$24K 0.03% 209
2023
Q4 		$252K Buy
3,116
+79
+3% +$6.15K 0.04% 180
2023
Q3 		$228K Buy
3,037
+11
+0.4% +$846 0.04% 179
2023
Q2 		$233K Buy
3,026
+74
+3% +$5.9K 0.04% 182
2023
Q1 		$245K Buy
2,952
+10
+0.3% +$828 0.04% 172
2022
Q4 		$253K Buy
+2,942
New +$233K 0.05% 170

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lodestar Private Asset Management's GILD Position: Q2 2026 in Review

Lodestar Private Asset Management reduced its Gilead Sciences (GILD) stake by 6.1% in Q2 2026, selling an estimated $19.8K and leaving 2,293 shares worth $290K. The position accounts for 0.03% of the portfolio, ranked #193.

Lodestar Private Asset Management first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. The position peaked at $341K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Lodestar Private Asset Management held 2,293 shares of Gilead Sciences worth $290K as of Q2 2026.
  • Lodestar Private Asset Management sold 150 Gilead Sciences shares in Q2 2026, an estimated $19.8K.
  • Gilead Sciences made up 0.03% of Lodestar Private Asset Management's portfolio in Q2 2026, its #193 holding.
  • Lodestar Private Asset Management first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
  • Lodestar Private Asset Management's Gilead Sciences position peaked at $341K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Lodestar Private Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.